Sandoz fails in Enbrel patent challenge, but Fed Circuit split

02-07-2020

Rory O'Neill

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

Bill Perry / Shutterstock.com

Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel (etanercept).


Sandoz, Amgen, Immunex, Roche, Enbrel, patent, biologic, biosimilar, Erelzi, Federal Circuit, New Jersey

LSIPR